Tumor cell-targeting by phage-displayed peptides
- 14 June 2002
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (7) , 606-612
- https://doi.org/10.1038/sj.cgt.7700476
Abstract
We isolated cancer cell–specific phages by subtracting and selecting complex peptide display phage libraries on cultured human cancer cells. The best candidate was selected by performing three rounds of subtraction before each of five selections on the human colorectal WiDr cell line. The phage showed more than 1000-fold higher binding efficiency for WiDr cells when compared to five other human cancer cell lines, including two of colorectal origin, and when compared to wild-type M13 phage. Fifty-fold higher binding efficiency was also seen for a human breast cancer cell line. We show that the WiDr cell binding of the selected phage was efficiently competed by the synthetic peptide HEWSYLAPYPWF, predicted from the phage sequence. This confirms that the specificity of the peptide is independent of the display by the phage coat proteins. The identified peptide may target biomarkers linked to colorectal cancer, and thus be useful for designing gene transfer vectors as well as diagnostic and prognostic tools for this disease.Keywords
This publication has 16 references indexed in Scilit:
- Selection of tumor-specific internalizing human antibodies from phage librariesJournal of Molecular Biology, 2000
- Genes Expressed in Human Tumor EndotheliumScience, 2000
- Selective Targeting of Gene Transfer to Vascular Endothelial Cells by Use of Peptides Isolated by Phage DisplayCirculation, 2000
- In vivo selection of sFv from phage display librariesJournal of Immunological Methods, 2000
- Biodistribution of filamentous phage-Fab in nude miceJournal of Immunological Methods, 1999
- Elucidation of muscle-binding peptides by phage display screeningMuscle & Nerve, 1999
- Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.Journal of Clinical Investigation, 1998
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse ModelScience, 1998
- αv Integrins as receptors for tumor targeting by circulating ligandsNature Biotechnology, 1997
- Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage librariesNature Medicine, 1996